The Board of Directors of Chong Kun Dang Pharmaceutical Corp. has authorized a buyback plan on October 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100,100 KRW | -1.96% |
|
-3.29% | -23.53% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.53% | 942M | |
+20.76% | 43.54B | |
+18.62% | 21.51B | |
+19.07% | 15.34B | |
+26.36% | 15.12B | |
+56.55% | 13.37B | |
-0.05% | 6.79B | |
-14.94% | 6.38B | |
-8.87% | 5.73B | |
+16.15% | 5.36B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.